(Q40365142)

19 September 2017

Proteinases in cardiovascular aneurysms and rupture: targets for therapy? (English)

1 reference

19 September 2017

Carmeliet P

1

1 reference

PMCID

300866

19 September 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

Journal of Clinical Investigation

19 September 2017

1 reference

19 September 2017

105

1 reference

19 September 2017

1519-1520

1 reference

19 September 2017

11

1 reference

Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms

19 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300866

Experimental techniques and models in the study of the development and treatment of abdominal aortic aneurysm

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300866

Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300866

Reduced transplant arteriosclerosis in plasminogen-deficient mice

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300866

Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300866

Basic science of abdominal aortic aneurysms: emerging therapeutic strategies for an unresolved clinical problem

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300866

Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300866

Prevention of aneurysm development and rupture by local overexpression of plasminogen activator inhibitor-1.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300866

Cell and extracellular matrix rejection in arterial concordant and discordant xenografts in the rat.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300866

Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure

20 August 2018

1 reference

12 December 2020

MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial

1 reference

12 December 2020

Demonstration of interstitial collagenase in abdominal aortic aneurysm disease

1 reference

12 December 2020

Plasminogen activator expression in human atherosclerotic lesions

1 reference

12 December 2020

Postinfarction ventricular septal rupture: the Wessex experience

1 reference

12 December 2020

Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice

1 reference

12 December 2020

Identifiers

DOI

10.1172/JCI10242

1 reference

19 September 2017

1 reference

19 September 2017

1 reference

PMCID

300866